All Stories

  1. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis
  2. Patients with systemic sclerosis frequently use phytopharmaceuticals: a cross-sectional survey
  3. Skin and lung fibrosis induced by bleomycin in mice: a systematic review
  4. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
  5. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry
  6. How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
  7. Rheumatological patients’ knowledge of, beliefs about, and practices in using phytotherapy: an exploratory study
  8. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
  9. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
  10. POS0628 BARICITINIB AMELIORATES BLEOMYCIN-INDUCED PULMONARY AND SKIN FIBROSIS VIA JAK 1/2 INHIBITON
  11. POS0199-PARE RHEUMATOLOGICAL PATIENTS’ KNOWLEDGE OF, BELIEFS ABOUT, AND PRACTICES IN USING PHYTOTHERAPY: AN EXPLORATORY STUDY
  12. Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study
  13. Assessment of diaphragmatic function by ultrasonography in patients with systemic sclerosis and its relation to clinical parameters
  14. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology
  15. Evaluation of Choroidal Vascularity Index in Systemic Sclerosis Patients
  16. Evaluation of Acute Phase Reactants in Patients with Ankylosing Spondylitis
  17. Evaluation of middle ear and hearing status of ankylosing spondylitis patients with wideband tympanometry and pure tone audiometry tests
  18. Comparison of pulmonary function, respiratory symptoms, functional level, and health-related quality of life in patients with systemic sclerosis according to smoking status
  19. Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis
  20. Warthin tumour and IgG-4-RD with pleural involvement: shared immunity or coincidence?
  21. Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS/MS
  22. POS0001 CAN SINGLE IMPUTATION TECHNIQUES FOR BASDAI COMPONENTS RELIABLY CALCULATE THE COMPOSITE SCORE IN AXIAL SPONDYLOARTHRITIS PATIENTS?
  23. AB1088 COVID-19 VACCINATION OF SPONDYLOARTHRITIS PATIENTS RECEIVING BIOLOGICAL THERAPY: REAL-LIFE DATA
  24. AB1312 HIGH PREVALENCE OF iRMD IN SARCOIDOSIS PATIENTS
  25. AB1106 HOW HAS THE COVID-19 PANDEMIC AFFECTED OUR RHEUMATOLOGY PATIENTS USING BIOLOGICAL/TARGETED DMARDS?
  26. AB0762 Incidence Of Anterior Uveitis In Axial Spondyloarthritis During Secukinumab Treatment: TWO YEARS REAL LIFE EXPERIENCE FROM TURKBIO REGISTRY
  27. AB1295 TREATMENT OUTCOMES OF ADULT-ONSET STILL’S DISEASE PATIENTS WITH BIOLOGICAL THERAPY
  28. AB0769 Treatment outcomes of patients with biological therapy during pregnancy and effect of pregnancy planning on treatment preferance of rheumatologists
  29. Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature
  30. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry
  31. Training Course Results of the Assessment of Modified Rodnan Skin Score in Scleroderma
  32. Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways
  33. Pulmonary to Systemic Flow Ratio in Precapillary Pulmonary Hypertension Without Left-to-Right Shunts: A Prognostic Implication of the Fick Method
  34. The prevalence of Sjögren’s syndrome and sicca symptoms in patients with systemic sclerosis and alpha-smooth muscle actin expression in biopsy specimens from minor salivary glands
  35. Effects of supervised exercise program and home exercise program in patients with systemic sclerosis: A randomized controlled trial
  36. Association of Leptin Levels and Disease Activity in Patients with Early Rheumatoid Arthritis
  37. A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients
  38. AB0459 ARTICULAR INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS
  39. AB0708 HIGH DRUG RETENTION RATES DESPITE B/TSDMARD INTERRUPTIONS IN COVID-19 PANDEMIC CHAOS
  40. AB0437 OESOPHAGEAL DILATATION ON HIGH-RESOLUTION CT CHEST IN SYSTEMIC SCLEROSIS: SIGNIFICANT INDEX?
  41. POS0750 THE CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHEMATOSUS WHO HAVE CONSTITUTIONAL SYMPTOMS AND LYMPHADENOPATHY
  42. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: A cross-sectional study
  43. Evaluation of limited hand mobility in systemic sclerosis patients by using “prayer sign” and “tabletop sign”
  44. Association between core stability and physical function, functional performance in patients with systemic sclerosis
  45. Postural balance and fall risk in patients with systemic sclerosis: A cross-sectional study
  46. TNF-α Inhibitors for the Management of Intractable Corneal Melt: Report of Three Cases and Review of the Literature
  47. Relationship of Wnt pathway activity and organ involvement in scleroderma types
  48. AB1071 COEXISTENCE OF FAMILIAL MEDITERRANEAN FEVER WITH SPONDYLOARTHRITIS: CLINICAL CHARACTERISTIC AND TREATMENT OUTCOMES
  49. AB0618 COMPREHENSIVE ANALYSIS OF AUTOANTIBODY PROFILE IN A TURKISH SYSTEMIC SCLEROSIS COHORT
  50. THU0378 DO COMORBIDITIES DECREASE THE FIRST TNF-INHIBITOR RETENTION AND TREATMENT RESPONSE IN AXIAL SPONDYLOARTHRITIS PATIENTS? DATA FROM TURKBIO
  51. SAT0097 DO COMORBIDITIES IMPACT PERSISTENCE OF FIRST TUMOR NECROSIS FACTOR INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS? DATA FROM TURKBIO
  52. SAT0344 LIMITED JOINT MOBILITY OF HAND IN SYSTEMIC SCLEROSIS PATIENTS BY USING “PRAYER” AND “TABLE TOP” SIGNS
  53. SAT0423 LONG-TERM SURVIVAL OF THE FIRST BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND THE EFFECT OF THE SELECTED TREATMENT ON DRUG SURVIVAL; TURKBIO REGISTRY
  54. FRI0099 THE IMPACT OF BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS ON THE COURSE OF RHEUMATOID ARTHRITIS-ASSOCIATED LUNG DISEASE
  55. THU0390 THE INFLUENCE OF OBESITY ON RETENTION AND TREATMENT RESPONSE OF SECUKINUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: REAL LIFE DATA FROM THE TURKBIO REGISTRY
  56. SAT0544 USE OF BIOLOGICAL DMARDS IN PATIENTS WITH ADULT-ONSET STILL’S DISEASE: RESULTS FROM TURKBIO REGISTRY
  57. Adult-onset still's disease, an unusual cause of severe acute liver injury: A case report
  58. Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
  59. FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE
  60. THU0690 DISEASE ACTIVITY CORRELATES WITH INSULIN RESISTANCE AND ADIPOCYTOKINES IN PATIENTS WITH DMARD-NAÏVE RHEUMATOID ARTHRITIS 
  61. AB1413-HPR FACTORS AFFECTING ACTIVITIES OF DAILY LIVING IN WOMEN INDIVIDUALS WITH SCLERODERMA
  62. AB0644 RESULTS OF A TRAINING COURSE FOR CALCULATION OF THE MODIFIED RODNAN SKIN SCORE IN SCLERODERMA
  63. THU0726-HPR THE COMPARISON OF ARTERIAL STIFFNESS, FUNCTIONAL EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN SYSTEMIC SCLEROSIS AND HEALTHY INDIVIDUALS
  64. FRI0416 THE EFFICACY AND SAFETY OF ANTI-TNF A TREATMENT IN ANKYLOSING SPONDYLITIS PATIENTS WITH LATE ONSET COMPARED TO THOSE WITH ADULT ONSET; THE DATA FROM TURKBIO REGISTRY
  65. AB1378-HPR EFFECT OF CLINICAL CHARACTERISTICS, HABITS, PHYSICAL ACTIVITY LEVELS AND FUNCTIONAL CAPACITY ON QUALITY OF LIFE IN SYSTEMIC SCLEROSIS PATIENTS
  66. SAT0625 TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAÏVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT – ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION
  67. Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
  68. Ochronosis Involvement and Extensity With 18F-FDG PET/CT
  69. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society
  70. Antioxidant Effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model
  71. Infliximab-associated focal segmental glomerulosclerosis in a patient with ankylosing spondylitis
  72. Gender does not make a difference in “composite psoriatic disease activity index (CPDAI)” in patients with psoriatic arthritis
  73. Association between Skin Thickness Measurements with Corneal Biomechanical Properties and Dry Eye Tests in Systemic Sclerosis
  74. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG/RANKL/TRAIL and Wnt inhibitors
  75. AB0860 Acute phase reactant change in ankylosing spondylitis patients
  76. FRI0105 Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis
  77. THU0317 Creating a european database of psoriatic arthritis patients treated in routine care – first, preliminary results from the eurospa research network collaboration
  78. AB0922 Metabolic syndrome is associated with active disease in psoriatic arthritis and may contribute to development of syndesmophytes
  79. AB0182 Molecular mechanisms mediating antioxidant effect of epigallocatechin-3-gallate in experimental scleroderma model
  80. AB0482 Similar efficacy of tofacitinib on disease activity in rheumatoid arthritis patients with and without previous biologicals; results from the turkbio registry
  81. THU0218 The efficacy and drug survival of the biosimilar infliximab (CT-P13) compared to the original reference infliximab in inflammatory rheumatic diseases; results from the turkbio registry
  82. AB0183 Vitamin d and vitamin d receptor in patients with scleroderma subtypes
  83. Effects of epigallocatechin-3-gallate (EGCG) on a scleroderma model of fibrosis
  84. Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma
  85. Parenchymal neuro-Behçet disease with erectile dysfunction and micturition disturbances: case report and literature review
  86. Focal myositis: a rare case report
  87. AB0658 Factors influencing elapsed time to a definitive diagnosis of systemic sclerosis and their relationship with the number of attending physicians and their medical specialization
  88. THU0714 Investigating the effects of hypermobility on balance variables
  89. AB0168 Protective effects of epigallocatechin 3 gallate on fibrosis in scleroderma model
  90. THU0314 Radiologic activity is the major determinant for physicians while deciding active disease in takayasu arteritis
  91. THU0271 The performance of different classification criteria in patients with primary sjogren's syndrome and analysis of their contribution for definitive diagnosis, when either criteria used alone or in combination
  92. Is There a Relationship between Maxillary Sinus Findings and Skeletal Malocclusion?
  93. AB0597 Adaptation of Ucla Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Questionnaire into Turkish
  94. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
  95. Risk factors for malignancy in systemic sclerosis patients
  96. Increased Frequency of Hand Osteoarthritis in Patients with Primary Sjögren Syndrome Compared with Systemic Lupus Erythematosus
  97. Effect of sex steroids on bone formation in an orthopedically expanded suture in rats
  98. Bilateral orbital pseudotumor in a patient with Takayasu arteritis: a case report and review of the literature
  99. The effect of fixed appliances on oral malodor from beginning of treatment till 1 year
  100. Minor salivary gland evaluation: Sjögren’s syndrome
  101. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes
  102. Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis
  103. Prevalence of Inflammatory Back Pain and Axial Spondyloarthritis Among University Employees in Izmir, Turkey
  104. FRI0210 A Lower Frequency of Inflammatory Back Pain in Male Patients with Ankylosing Spondylitis Compared with Female Patients
  105. SAT0261 Asdas can be Reliably Calculated When Only the Patient's Overall Basdai Score is Available, but not the Score(S) of its Individual Component(S): Table 1.
  106. AB1120 Comparison of Long-Term Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis: A Single Center Turkish Experience Over a Decade
  107. FRI0229 Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups
  108. AB0764 Gender Differences in Axial Spondyloarthritis
  109. FRI0260 The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center: Table 1.
  110. FRI0227 The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups: Table 1.
  111. Telephone interview strategy can be used for screening inflammatory back pain in the community
  112. Morphological Nasal Changes Associated with Rapid Maxillary Expansion
  113. Body composition in patients with rheumatoid arthritis is not different than healthy subjects
  114. Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever
  115. FRI0148 Family History in Turkish Ankylosing Spondylitis Patients Receiving Anti-TNF Therapy: Table 1.
  116. AB0712 Level of Awareness of Inflammatory Back Pain and Axial Spondyloarthritis among Medical Specialties Who Frequently SEE Patients with Low Back Pain
  117. SAT0361 Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with Non–Radiographic Axial Spondylarthritis and Ankylosing Spondylitis; Results from TURKBIO Registry: Table 1.
  118. AB0744 There is NO Relationship between Glucagon like Peptide-1 and Inflammation in Psoriasis and Psoriatic Arthritis: Table 1.
  119. Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis
  120. Familial Mediterranean fever: An updated review
  121. The prevalence of gout in an urban area of Izmir, Turkey: A population-based epidemiological study
  122. Echocardiographic Parameters Predicting the Mortality and Morbidity in Pulmonary Hypertension
  123. THU0225 Prevalence of takayasu’s arteritis in IZMIR, turkey: A multicenter study
  124. High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis
  125. Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis
  126. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial mediterranean fever
  127. Prevalence of primary Sjogren’s syndrome in Turkey: a population-based epidemiological study
  128. A Large-Scale Outbreak of Trichinellosis Caused byTrichinella britoviin Turkey
  129. M694V mutation may have a role in susceptibility to ankylosing spondylitis
  130. A Case of Adult-Onset Still's Disease Complicated with Diffuse Alveolar Hemorrhage
  131. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease
  132. Hyperuricemia and its related factors in an urban population, Izmir, Turkey
  133. Atypical infectious mononucleosis in a patient receiving tumor necrosis factor alpha inhibitory treatment
  134. Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy
  135. Clinical history for inflammatory back pain in ankylosing spondylitis: the sensitivity, specificity and consistency of clinical features
  136. Ankylosing spondylitis and spondylarthropathy presenting with a clinical picture of adult onset Still's disease: case series
  137. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment
  138. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients
  139. Irritable Bowel Syndrome in Persons Who Acquired Trichinellosis
  140. FREQUENCY AND SEVERITY OF MUSCULOSKELETAL SYMPTOMS IN HUMANS DURING AN OUTBREAK OF TRICHINELLOSIS CAUSED BY TRICHINELLA BRITOVI
  141. Body composition, insulin, and leptin levels in patients with ankylosing spondylitis
  142. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever
  143. Reply
  144. Impaired endothelial function in patients with ankylosing spondylitis
  145. Acute Trichinellosis in Children Compared With Adults
  146. Reflex sympathetic dystrophy syndrome due to arteriovenous fistula
  147. Skewed X chromosome inactivation in blood cells of women with scleroderma
  148. Familial Mediterranean Fever (FMF) in Turkey
  149. Skewed X chromosome inactivation in scleroderma: Comment on the article by Özbalkan et al
  150. Thyrotoxic Periodic Paralysis in a Turkish Male; The Recurrence of the Attack after Radioiodine Treatment
  151. Thrombosis and priapism in a patient with Henoch-Schonlein purpura
  152. Articular, B-cell, non-Hodgkin?s lymphoma mimicking rheumatoid arthritis: synovial involvement in a small hand joint
  153. A case of recurrent pancreatitis due to hyperlipidemia misdiagnosed as familial Mediterranean fever
  154. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder
  155. A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations
  156. Seroprevalence of Borrelia burgdorferi in patients with Beh�et's disease
  157. A case with recurrent calf pain and swelling: recurrent spontaneous calf haematoma
  158. Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: A rare occurrence